Bumetanide and Thalomid drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide (bumetanide) and Thalomid (thalidomide). Common drug interactions include synovial cyst among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Thalomid. It is created by eHealthMe based on reports of 54 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Thalomid?

Thalomid has active ingredients of thalidomide. It is often used in multiple myeloma. eHealthMe is studying from 38,099 Thalomid users. Check the latest studies of Thalomid.



On Jul, 10, 2026

54 people who take Bumetanide and Thalomid together, and have interactions are studied.

Bumetanide and Thalomid drug interactions.

What are the common drug interactions of Bumetanide and Thalomid, by gender? *:

female:

  1. Synovial cyst (cyst of joint filled with synovial fluid)
  2. Fibroma (tumours that are composed of fibrous or connective tissue)
  3. Herpes zoster
  4. Oedema mouth (swelling of mouth)
  5. Respiratory failure (inadequate gas exchange by the respiratory system)
  6. Tooth extraction
  7. Blepharitis (chronic inflammation of the eyelid)
  8. Carpal tunnel decompression
  9. Polyp
  10. Actinomycosis (infection that causes sores, or abscesses)

male:

  1. Pneumonia
  2. Blood potassium decreased
  3. Fall
  4. Pleural effusion (water on the lungs)
  5. Urinary tract infection bacterial
  6. Asthenia (weakness)
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Blood lactate dehydrogenase increased
  9. Constipation
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

What are the common drug interactions of Bumetanide and Thalomid, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Pulmonary embolism (blockage of the main artery of the lung)
  2. Cardiac failure congestive
  3. Back disorder
  4. Blood creatine phosphokinase increased
  5. Blood immunoglobulin a increased
  6. Bone disorder
  7. Bruxism (habitual grinding of the teeth, typically during sleep)
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  9. Cardiac disorder
  10. Carotid artery stenosis (narrowing of carotid artery)

What are the existing conditions these people have? *

  1. Pain: 18 people, 33.33%
  2. Metastases To Bone (cancer spreads to bone): 17 people, 31.48%
  3. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 7 people, 12.96%
  4. Insomnia (sleeplessness): 3 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Thalomid?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bumetanide and Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Thalomid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Thalomid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide and thalidomide (the active ingredients of Bumetanide and Thalomid, respectively), and Bumetanide and Thalomid (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: